A new federal rule set to take effect later this month will suspend the de minimis exemption for shipments valued under $800, impacting millions of Americans who rely on affordable prescription drugs from Canada. This change, aimed at collecting tariffs and preventing illegal imports, will impose additional fees and registration requirements on low-value international shipments, potentially leading to delays and increased costs for medications. Advocates argue this rule will significantly harm patients seeking cheaper alternatives, as some drugs imported from Canada are substantially less expensive than their U.S. counterparts. AI
RANK_REASON Policy change impacting a large number of consumers with significant cost implications. [lever_c_demoted from significant: ic=1 ai=0.1]
- Campaign for Personal Prescription Importation
- Canada
- Donald Trump
- Eliquis
- JAMA Network Open
- Ken Hunter
- Susan Marie Lloyd
- Trumprx
- U.S.
- U.S. Customs and Border Protection
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →